perindopril has been researched along with Dyslipidemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Degli Esposti, L; Gambera, M; Nati, G; Perone, F; Perrone, V; Tagliabue, PF; Veronesi, C; Volpe, M | 1 |
| Zlatohlávek, L | 1 |
2 other study(ies) available for perindopril and Dyslipidemia
| Article | Year |
|---|---|
Treatment with Free Triple Combination Therapy of Atorvastatin, Perindopril, Amlodipine in Hypertensive Patients: A Real-World Population Study in Italy.
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atorvastatin; Biomarkers; Blood Pressure; Calcium Channel Blockers; Databases, Factual; Drug Therapy, Combination; Dyslipidemias; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Italy; Lipids; Male; Medication Adherence; Middle Aged; Perindopril; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome | 2019 |
Euvascor - early intervention of hypertension and dyslipidaemia (dual combination of atorvastatin and perindopril).
Topics: Atorvastatin; Cardiovascular Diseases; Czech Republic; Dyslipidemias; Humans; Hypertension; Perindopril | 2020 |